We compared the concentration-response relationship of intralobar pulmonary arteries to I-norepinephrine with that of femoral arteries from newborn lambs. In addition, the effect of inhibition of the neuronal and extra-neuronal uptake mechanisms on these concentration-response relationships was examined.
Concentration-response curves on 10 intralobar pulmonary arteries were performed with and without inhibition of the uptake mechanisms. Uptake inhibition shifts the curve to the left; thus, the -log EC50 with uptake inhibition (6.63 f 0.15) is greater than that without uptake inhibition (6.13 f 0.14). Similar curves on 10 femoral arteries demonstrated that the -log EC50 with and without uptake inhibition (6.20 f 0.13 and 6.00 f 0.04, respectively) are not statistically different.
Because, in the presence of intact uptake mechanisms the concentration of I-norepinephrine in the a-receptor microenvironment is less than that placed in the organ bath, the appropriate comparison of pulmonary and femoral arterial response to 1-norepinephrine stimulation requires uptake inhibition in both vessels. The concentration-response curve with uptake inhibition for the intralobar pulmonary artery is significantly to the left of that for the femoral; the -log ECS0 for the pulmonary vessel (6.63 f 0.15) is greater than that of the femoral vessel (6.20 f 0.13). The intralobar pulmonary artery in vitro is more sensitive to I-norepinephrine stimulation than is the femoral.
Persistent pulmonary vasoconstriction is a serious, often life threatening problem in the neonatal period (5, 6, 21, 25, 26).
There is evidence which suggests that a-adrenergic constriction may be involved in the control of the neonatal pulmonary circulation (4, 14) . Tolazoline, an a-adrenergic antagonist, has been used successfully to manage some babies with persistent pulmonary vasoconstriction (1 1, 17) although the therapeutic benefit of this drug also could be related to its histaminergic effects (10) . Much remains to be learned about the basic physiology and pharmacology of the newborn pulmonary vascular aadrenergic system. Little is known about the relative sensitivities of various vascular beds in the neonate to a-adrenergic stimulation. Differences in sensitivity of different vascular beds to adrenergic agonists such as 1-norepinephrine could have physiologic consequences. As an initial approach to this problem, we compared the concentration-response relationship to l-norepinephrine of intralobar pulmonary arteries with that of femoral arteries from newborn lambs. In addition, as a prerequisite to this study, the effect of inhibition of the neuronal and extraneuronal uptake mechanisms on these concentration-response relationships was examined. Differences between neonatal pulmonary and femoral arteries were found in both the concentration-response relationship and the effect of inhibition of the uptake systems.
MATERIALS AND METHODS
Fourteen neonatal lambs (age, 2-8 d; average 4 d) were anesthetized with chloralose (50 mglkg; Sigma Chemical Co., St. Louis, MO). Femoral arteries were placed in Krebs-bicarbonate buffer; pH 7.4, bubbled with 95% 02-5% COz. The left lung was removed, and the pulmonary arterial tree was dissected to the STIMULATION BY apex of each lobe. Fourth generation vessels were cut at their, origin, and the intralobar, third generation vessels were removed and placed in Krebs-bicarbonate buffer.
Approximately 2-mm arterial rings were mounted on hooks made from 25 gauge needles (Becton, Dickinson and Co., Ruth-, erford, NJ) and placed in jacketed organ baths (Van Gillum Scientific Glass, Memphis, TN). The bottom attachment of each ring was fixed whereas the top hook was connected to a force transducer with microscale accessory (Statham Model 'lfC-2 transducer from Beckman Instruments, Inc., Schiller Park, IL). Organ bath jackets were circulated with heated water (Haake, Inc., Saddle Brook, NJ) to maintain a bath temperature of 37°C. The signals from the force transducers were amplified and recorded on a direct writing recorder (R-511A Dynograph Recorder, Beckman Instruments, Inc.).
The length of the rings was adjusted to give an initial baseline tension of 1 g in the pulmonary vessels and 1.5 g in the femoral vessels. These baseline tensions were shown in preliminary experiments to be easily definable and to correspond to approximately 1.5 times the unstretched length of each of the two vessel types. This baseline length is near the maximum difference in the active and passive length-tension curves but would not overly stretch the vascular smooth muscle (1 3). The rings were allowed to reach a steady state (1-1.5 h) with bath changes every 20 min.
Fresh stock solutions of all drugs were made on the morning of an experiment. They were placed in opaque vials and kept on ice. 1-Norepinephrine (Sigma) stocks were made in 10 mM ascorbic acid (Sigma). All experiments were performed in a darkened room to prevent photodecomposition of the catecholamine.
Concentration-response curves were performed with all solutions containing 1 x M, d,l-propranolol (Sigma) to block Padrenergic receptors. Concentration-response curves with uptake inhibition were carried out with 3 X lo-' M cocaine HCl (Merck & Co., Inc., Rahway, NJ) and 1 X M hydrocortisone (Sigma), inhibitors of neuronal and extra-neuronal uptake respectively (2, 3, 12) . Neither P-blockade nor uptake inhibition had a significant effect on baseline tension. No more than two curves were done on a vessel in a given day; spontaneous return to baseline was allowed between curves. Order of curves (with and without uptake inhibition) was predetermined so that there would be equal numbers of first curves with and without uptake inhibitors.
1-Norepinephrine concentration-response curves were performed by sequentially increasing the bath concentration from 1 x lo-* M to 1 x M. At each concentration change, the bath was emptied, washed with, and then refilled with a new solution. This washing and refilling procedure caused no change in tension during the baseline equilibration period. The response at each concentration was defined as the change in tension from baseline divided by the maximum change in tension for that vessel. The use of this definition of "response" has been shown to produce 1-norepinephrine concentration-response curves that are independent of the mechanical baseline conditions (28) and, thus, is useful in comparing the a-adrenergic sensitivities of two types of arterial rings.
For each curve reported on a pulmonary vessel under any of the described conditions, a curve was performed simultaneously on a femoral vessel from the same lamb under identical conditions. If, for technical reasons, a curve on an individual vessel could not be completed, the results of its companion vessel were not used. Ten studies on each vessel type with and without uptake inhibition were completed.
Analysis of variance was used for the curves and the paired t test for -log ECsos. The -log EC50 is the negative value of the logarithm of the norepinephrine concentration expressed in moll L which gives 50% of the maximum response for a given vessel. The relationship of the -log EC50 to ring diameter was determined by use of linear regression least-squares analysis with calculation of correlation coefficient. Ring diameters were compared using the paired t test. Values shown represent the mean + the standard error of the mean for 10 vessels. All differences cited are significant at P < 0.05.
RESULTS

EfSect of uptake inhibition. The existence of neuronal (uptake,)
and extra-neuronal (uptakell) mechanisms for the removal of 1-norepinephrine and other catecholamines from the extracellular space has been documented in several tissues (12, 15, 19) . These uptake mechanisms may lower the concentration of catecholamines in the microenvironment of the a-adrenergic receptor; therefore, it has become routine to inhibit these uptake mechanisms when performing I-norepinephrine concentration-response curves so that the a,-receptor is exposed to the same concentration of agonist that exists in the remainder of the organ bath. A necessary preliminary step before examining the relative sensitivities of neonatal pulmonary and systemic vessels is to examine the effect of inhibition of the uptake mechanisms. Figure 1 shows the results of concentration-response curves on 10 intralobar pulmonary arteries performed with and without inhibition of the uptake mechanisms. Uptake inhibition shifts the curve to the left; thus, the -log ECso with uptake inhibition (6.63 & 0.15) is greater than that without uptake inhibition (6.13 f 0.14). The curve with uptake inhibition represents the true position of the concentration-response curve because, in that situation, the a,-adrenergic receptor is exposed to the same concentration as is placed in the organ bath. Figure 2 shows similar results for 10 femoral arteries. The curves with and without uptake inhibition are not different. The -log ECSos with and without uptake inhibition (6.20 f 0.13 and 6.00 f 0.04, respectively) are not significantly different. In this experimental model, the uptake mechanisms alter the concentration-response relationship in neonatal intrapulmonary arteries but not in neonatal femoral arteries. Inhibition of the uptake mechanisms did not change the absolute value of the maximum change in tension in either pulmonary arteries (0.83 + 0.13 g with uptake inhibition and 0.88 f 0.13 g without uptake inhibition) or femoral arteries (2.5 + 0.2 g with uptake inhibition and 2.8 f 0.3 g without uptake inhibition).
Least-squares analyses of -log ECso versus ring diameter yielded correlation coefficients (degrees of freedom = 9) of 0.508 and 0.065 for the femoral and pulmonary rings, respectively, both of which are not significant. Similarly, the shift of the -log E C~O of the pulmonary arterial rings caused by uptake inhibition was not significantly related to ring diameter (correlation coefficient = 0.3 10).
Comparison of the pulmonary andfemoral responses. The shift of the concentration-res~onse relations hi^ bv uutake inhibition in the pulmonary vessels implies that in themabsence of the inhibitors, the concentration of 1-norepinephrine in the a,-receptor microenvironment is less than the concentration placed in the organ bath. The appropriate manner in which to compare the response to 0,-receptor stimulation is to inhibit uptake in both vessels. Figure 3 shows the concentration-response curves of 10 pulmonary vessels and the 10 femoral vessels with uptake inhibition. The concentration-response curve for the intralobar pulmonary artery is significantly to the left of that for the femoral artery; thus, the -log for the pulmonary vessel (6.63 + 0.15) is significantly greater than that for the femoral (6.20 + 0.13).
Femoral ring diameter (2.25 + 0.16 mm) measured in vitro was less than pulmonary ring diameter (2.78 + 0.17 mm) measured similarly. But, least-squares analysis of the difference in the -log ECso of the paired pulmonary and femoral arterial rings versus the difference in their respective diameters showed no significant correlation (correlation coefficient = 0.503; degrees of freedom = 9).
DISCUSSION
The potential role far a-adrenergic constriction in the control of the pulmonary vasculature is suggested by observations of aadrenergic pulmonary vasoconstriction in a variety of experimental models (3, 4, 12, 16, 27) . Furthermore, a-adrenergic pulmonary vasoconstriction in the neonatal lamb may be altered by hypoxia (20) ; circulating 1-norepinephrine levels are elevated markedly in stressed human neonates (18, 24) and a-adrenergic blockade may be useful in treating neonatal pulmonary hypertension (1 1, 17) . a-Adrenergic stimulation may play an important role in the control of the perinatal pulmonary circulation and in the generation of persistent pulmonary hypertension in the neonate.
In addition, differential effects of vasoactive agents on pulmonary and systemic vessels could be important physiologically in the neonate in whom the pulmonary and systemic circulations are connected by the ductus arteriosus and foramen ovale. As an initial approach to this subject, we compared the concentrationresponse relationship of intralobar pulmonary arteries to 1- norepinephrine with that of femoral arteries from newborn lambs. When the neuronal and extra-neuronal uptake mechanisms are inhibited, so that the al-receptors are exposed to the same concentration as is present in the remainder of the organ bath, the pulmonary arteries are more sensitive to l-norepinephrine stimulation than are the femorals. There are a variety of potential mechanisms for this situation including differences in a,-receptor sensitivity, distribution, or density, or differences in intracellular biochemical events linking receptor binding to tension development. The present studies cannot address these various possibilities. Similarly, conclusions about potential differences in the entire pulmonary and systemic vasculatures cannot be drawn from isolated vessel studies; however, the present information does confirm the heterogeneity of response to aadrenergic stimulation in various vessels as suggested by Bevan (3) and encourages further investigation in this area.
Our studies of the effect of uptake inhibition were performed as a preliminary step in these experiments. The failure of uptake inhibition to shift the concentration-response curve of the femoral vessels does not rule out the presence of uptake by these vessels. One possible explanation would be that the uptake mechanism may be saturated at a concentration below the threshold of the a,-adrenergic receptor in the femoral vessel. Because the pulmonary al-adrenergic receptor may be more sensitive, it could compete with the uninhibited uptake mechanisms for 1 -norepinephrine, particularly in the lower concentrations on the concentration-response curve (1 7). Other possibilities for the apparent differences between the two vessels in uptake could be differences in density or anatomic disposition of adrenergic neuronal uptake sites in the two vessels, undefined effects of az-receptors, or a truly more active endothelial and smoooth muscle uptake in the pulmonary vasculature. The latter possibility is supported by several studies pointing to the importance of endothelial removal of norepinephrine and other vasoactive substances from the circulation (1, 7-9, 22, 23) . Conclusions about the physiologic effect of the uptake mechanisms in the newborn period based on these isolated vessel studies remains speculative.
The small difference in the in vitro diameters of the pulmonary and femoral arterial rings resulted from the necessity of avoiding the numerous side branches of the pulmonary vessel when choosing a ring. It is unlikely that the differences demonstrated between in vitro pulmonary and femoral vessel rings can be attributed to STIMULATION BY 1-NOREPINEPHRINE 247 this small difference in ring diameter because there was no significant correlation between ring diameter and -log ECSO within each group or between difference in ring diameter and difference in -log ECso when comparing pulmonary and femoral arterial rings.
In summary, the present study demonstrates that neonatal ovine intrapulmonary lobar arteries and femoral arteries differ both in their 1-norepinephrine concentration-response relationship and in the effect of inhibition of the uptake mechanisms. These observations suggest a heterogeneity of the response to 1-norepinephrine in the neonatal vasculature.
